TY  - JOUR
AU  - Huerta, Ana
AU  - Arjona, Emilia
AU  - Portoles, Jose
AU  - Lopez-Sanchez, Paula
AU  - Rabasco, Cristina
AU  - Espinosa, Mario
AU  - Cavero, Teresa
AU  - Blasco, Miquel
AU  - Cao, Mercedes
AU  - Manrique, Joaquin
AU  - Cabello-Chavez, Virginia
AU  - Suñer, Marta
AU  - Heras, Manuel
AU  - Fulladosa, Xavier
AU  - Belmar, Lara
AU  - Sempere, Amparo
AU  - Peralta, Carmen
AU  - Castillo, Lorena
AU  - Arnau, Alvaro
AU  - Praga, Manuel
AU  - Rodriguez de Cordoba, Santiago
PY  - 2017
DO  - 10.1016/j.kint.2017.06.022
UR  - http://hdl.handle.net/10668/11581
T2  - Kidney international
AB  - Pregnancy-associated atypical hemolytic uremic syndrome (aHUS) refers to the thrombotic microangiopathy resulting from uncontrolled complement activation during pregnancy or the postpartum period. Pregnancy-associated aHUS is a devastating disease for...
LA  - en
KW  - cesarean section
KW  - complement
KW  - eculizumab
KW  - hemolytic uremic syndrome
KW  - postpartum
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - Atypical Hemolytic Uremic Syndrome
KW  - Cesarean Section
KW  - Complement Activation
KW  - Complement C3b Inactivator Proteins
KW  - Complement Factor H
KW  - Female
KW  - Gene Conversion
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Mutation
KW  - Parity
KW  - Plasma Exchange
KW  - Postpartum Period
KW  - Pregnancy
KW  - Pregnancy Complications
KW  - Registries
KW  - Renal Dialysis
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Spain
KW  - Thrombotic Microangiopathies
KW  - Treatment Outcome
TI  - A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
TY  - research article
VL  - 93
ER  -